PT - JOURNAL ARTICLE AU - Saper, Vivian E AU - Chen, Guangbo AU - Deutsch, Gail H AU - Guillerman, R Paul AU - Birgmeier, Johannes AU - Jagadeesh, Karthik AU - Canna, Scott AU - Schulert, Grant AU - Deterding, Robin AU - Xu, Jianpeng AU - Leung, Ann N AU - Bouzoubaa, Layla AU - Abulaban, Khalid AU - Baszis, Kevin AU - Behrens, Edward M AU - Birmingham, James AU - Casey, Alicia AU - Cidon, Michal AU - Cron, Randy Q AU - De, Aliva AU - De Benedetti, Fabrizio AU - Ferguson, Ian AU - Fishman, Martha P AU - Goodman, Steven I AU - Graham, T Brent AU - Grom, Alexei A AU - Haines, Kathleen AU - Hazen, Melissa AU - Henderson, Lauren A AU - Ho, Assunta AU - Ibarra, Maria AU - Inman, Christi J AU - Jerath, Rita AU - Khawaja, Khulood AU - Kingsbury, Daniel J AU - Klein-Gitelman, Marisa AU - Lai, Khanh AU - Lapidus, Sivia AU - Lin, Clara AU - Lin, Jenny AU - Liptzin, Deborah R AU - Milojevic, Diana AU - Mombourquette, Joy AU - Onel, Karen AU - Ozen, Seza AU - Perez, Maria AU - Phillippi, Kathryn AU - Prahalad, Sampath AU - Radhakrishna, Suhas AU - Reinhardt, Adam AU - Riskalla, Mona AU - Rosenwasser, Natalie AU - Roth, Johannes AU - Schneider, Rayfel AU - Schonenberg-Meinema, Dieneke AU - Shenoi, Susan AU - Smith, Judith A AU - Sönmez, Hafize Emine AU - Stoll, Matthew L AU - Towe, Christopher AU - Vargas, Sara O AU - Vehe, Richard K AU - Young, Lisa R AU - Yang, Jacqueline AU - Desai, Tushar AU - Balise, Raymond AU - Lu, Ying AU - Tian, Lu AU - Bejerano, Gill AU - Davis, Mark M AU - Khatri, Purvesh AU - Mellins, Elizabeth D ED - TI - Emergent high fatality lung disease in systemic juvenile arthritis AID - 10.1136/annrheumdis-2019-216040 DP - 2019 Dec 01 TA - Annals of the Rheumatic Diseases PG - 1722--1731 VI - 78 IP - 12 4099 - http://ard.bmj.com/content/78/12/1722.short 4100 - http://ard.bmj.com/content/78/12/1722.full SO - Ann Rheum Dis2019 Dec 01; 78 AB - Objective To investigate the characteristics and risk factors of a novel parenchymal lung disease (LD), increasingly detected in systemic juvenile idiopathic arthritis (sJIA).Methods In a multicentre retrospective study, 61 cases were investigated using physician-reported clinical information and centralised analyses of radiological, pathological and genetic data.Results LD was associated with distinctive features, including acute erythematous clubbing and a high frequency of anaphylactic reactions to the interleukin (IL)-6 inhibitor, tocilizumab. Serum ferritin elevation and/or significant lymphopaenia preceded LD detection. The most prevalent chest CT pattern was septal thickening, involving the periphery of multiple lobes ± ground-glass opacities. The predominant pathology (23 of 36) was pulmonary alveolar proteinosis and/or endogenous lipoid pneumonia (PAP/ELP), with atypical features including regional involvement and concomitant vascular changes. Apparent severe delayed drug hypersensitivity occurred in some cases. The 5-year survival was 42%. Whole exome sequencing (20 of 61) did not identify a novel monogenic defect or likely causal PAP-related or macrophage activation syndrome (MAS)-related mutations. Trisomy 21 and young sJIA onset increased LD risk. Exposure to IL-1 and IL-6 inhibitors (46 of 61) was associated with multiple LD features. By several indicators, severity of sJIA was comparable in drug-exposed subjects and published sJIA cohorts. MAS at sJIA onset was increased in the drug-exposed, but was not associated with LD features.Conclusions A rare, life-threatening lung disease in sJIA is defined by a constellation of unusual clinical characteristics. The pathology, a PAP/ELP variant, suggests macrophage dysfunction. Inhibitor exposure may promote LD, independent of sJIA severity, in a small subset of treated patients. Treatment/prevention strategies are needed.